愛尚它®強鈣配方粉末

愛尚它^®強鈣配方粉末主要好處： 

·     鈣：構成牙齒與骨骼的主要成分。有助維持心臟、肌肉正常收縮及神經的感應性。有助控制細胞的通透性。維持骨骼及牙齒的健康。

·     維生素D：有助鈣及磷的吸收及利用。幫助骨骼及牙齒的生長發育。幫助維持血鈣的正常濃度。維持神經、肌肉生理的正常功能。幫助骨骼鈣化。

·     鎂：構成牙齒與骨骼的成分。與鈉、鉀、鈣共同維持心臟、肌肉及神經等正常功能。

愛尚它^®強鈣配方粉末的主要成份： 

鈣

奶類含有高濃度的鈣，其他含豐富鈣質的食物包括羽衣甘藍、大白菜、芥菜、綠花椰菜、青江菜及豆腐。鈣是一種必需礦物質，具有多方面的生物用途，存在於骨骼中的鈣主要為羥基磷灰石的形式(Ca₁₀ (PO₄)₆ (OH)₂)。 

羥基磷灰石約佔骨骼整體重量的四成。骨骼擁有結構上的先決條件，並作為鈣的儲存庫。除了作為骨頭及牙齒的主要成份外，鈣還支援正常的肌肉收縮、神經健康、心跳節奏、血液凝固等重要生理功能。

人體每日必需攝取足夠的鈣，以維持最佳的骨質密度、骨骼及牙齒健康，另外，鈣還顯示能舒緩女性經前症候群引起的不適。若人體每日吸收的鈣質不足，就會從骨頭裏提取鈣來使用。

鎂

富含鎂的食物包括粗穀類、堅果及綠色蔬菜。綠葉蔬菜由於其葉綠素含量高，因此是鎂的豐富來源。肉類、澱粉、奶製品及精製或加工食品的鎂含量較低。 

鎂是骨頭內礦物質部份的其中一種成份，能支援成年人體內鉀及鈣的正常代謝。鎂能有助鉀、磷、鈣維持正常含量。鎂亦支援細胞內鈣的傳送，以供人體使用。鎂促進肌肉及神經組織的正常功能，以及蛋白質、脂質及碳水化合物的正常合成。 

鎂促進正常的神經功能及新陳代謝。很重要的是，鎂還支援人體發展健康骨骼、牙齒及肌肉的能力。鎂與鈣及維生素D相互合作，有助維持骨骼強壯。 

錳

錳是一種大量存在於植物及動物物質內的礦物質。含錳最豐富的食物來源包括全穀物、堅果、葉菜類及茶。含錳濃度最高的是穀物的穀皮部份，但通常穀物在加工時，穀皮都會被去除。 

人體組織只含有微量的錳元素，主要儲存於骨頭、肝臟、腎臟及胰臟。

維生素B2

維生素B2存在於肝臟、奶類製品、深綠色蔬菜及部份海鮮中。維生素B2的角色是輔酵素，與其他維生素B合作。維生素B2促進人類正常生長，並增進皮膚健康。維生素B2作為電子輸送鏈的一部份，能促進食物轉化成能量的正常過程，在微觀的層面上推動細胞能量。維生素B2為水溶性，除非是極微量，否則不可被儲存於體內，因此，必須每日補充。 

維生素C

蘊藏最豐富維生素C的食物來源包括所有柑橘類水果（柳橙、葡萄柚、檸檬及柑橘）、草莓、蕃茄、綠花椰菜、小甘藍、椒類及哈蜜瓜。維生素C是一種「脆弱」的維生素，經過烹煮或食物曝露於氧氣中就很容易受損。 

維生素C支援身體使用其他多種維生素及礦物質的能力，如：硫胺素、核黃素、泛酸、生物素、葉酸、B12、視黃酫、α-生育酚及礦物鈣。維生素C在正常的葉酸及部份氨基酸的代謝作用上，擔當輔因子或輔助者的角色。作為一種有效的抗氧化物，維生素C還支援鐵在小腸的吸收，並支援膠原蛋白的正常合成。 

維生素C 成為了全球最受歡迎的維生素。由於人體自身不能製造維生素C ，因此，這亦成為了人們需要服用維生素C補充品最有說服力的理據。 

壓力問題也可能與維生素C 不足有關。另外，吸煙及部份藥物或會阻礙人體吸收維生素C的能力。由於維生素C為水溶性，因此每日都會排泄出體外，而因為人們日常進食的食物維生素C含量不足，所以服用補充品會對人體有益。 

維生素D

人類取得維生素D的主要途徑為適量曬太陽。含有維生素D的食物來源包括添加維生素D的奶類、魚肝油及含脂肪魚類如鮭魚，而蛋黃及肝臟也含少量維生素D。 

維生素D促進鈣及磷的吸收，並支援幾種參與鈣的吸收及儲存過程的蛋白質製造。維生素D與鈣相互合作，促進骨骼強壯、堅固。 

支持愛尚它^®強鈣配方粉末的科學研究：

• Abbott L, Nadler J, Rude RK. Magnesium deficiency in alcoholism: possible contribution to osteoporosis and cardiovascular disease in alcoholics. Alcohol Clin Exp Res. 1994; 18:1076-1082.
• Allender PS, Cutler JA, Follman D, et al. Dietary calcium and blood pressure: meta—analysis of randomized clinical trials. Ann Intern Med. 1996; 124:825-831.
• Altura BM, Altura BT. Role of magnesium and calcium in alcohol-induced hypertension and strokes as probed by in vivo television microscopy, digital image microscopy, optical spectroscopy, 31P-NMR, spectroscopy and a unique magnesium ion-selective electrode. Alcohol Clin Exp Res. 1994; 18:1057-1068.
• Baly DL, Schneiderman JS, Garcia-Welsh AL. Effect of manganese deficiency on insulin binding, glucose transport and metabolism in rat adipocytes. J Nutr. 1990; 120:1075-1079.
• Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med 1999;340:101-107.
• Baron JA, Tosteson TD, Wargovich MJ, et al. Calcium supplementation and rectal mucosal proliferation: a randomized controlled trial. J Natl Cancer Inst 1995;87:1303-1307.
• Baxter GF, Sumeray MS, Walker JM. Infant size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studies. Lancet. 1996; 348:1424-1426.
• Bell L, Halstenson CE, Halstenson CJ, et al. Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med. 1992; 152:2441-2444.
• Bostick RM, Kushi LH, Wu Y, et al. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 1999;149:151-160.
• Britton J, Pavord I, Richards K, et al. Dietary magnesium, lung function, wheezing, and airway hyper-reactivity in a random adult population sample. Lancet. 1994; 344:357-362.
• Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med. 1996; 125:961-968.
• Casscells W. Magnesium and myocardial infarction. Lancet. 1994; 343:807-809.
• Christiansen CW, Rieder MA, Silverstein EL, Gencheff NE. Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Circulation. 1995; 92:2617-2621.
• Christin Marandino, Vegetarian Times, August 1998
• Curhan GC, Willett WC, Speizer FE, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk of kidney stones in women. Ann Intern Med. 1997; 126:497-504.
• Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density on men and women 65 years of age and older. N Engl J Med. 1997; 337:670-676.
• de Lourdes Lima M, Cruz T, Carreiro Pousada J, et al. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care. 1998; 21:682-686.
• Dietary Reference Intakes for Calcium, Phosphorous, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press; 1997.
• Durlach J, Durlach V, Bac P, et al. Magnesium and therapeutics. Magnes Res. 1994; 7:313-328.
• Elisaf M, Merkouropoulos M, Tsianos EV. Siamopoulos KC. Pathogenetic mechanisms of hypomagnesemia in alcoholic patients. J Trace Elem Med Biol. 1995; 9:210-214.
• Facchinetti F, Borella P, Sances G, et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol. 1991; 78:177-181.
• Garland CF, Garland FC, Gorham ED. Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann NY Acad Sci. 1999; 889:107-119.
• Gong H, Amemiya T. Optic nerve changes in manganese-deficient rats. Exp Eye Res. 1999; 68:313-320.
• Gullestad L, Dolva LO, Soyland E, et al. Oral magnesium supplementation improves metabolic variables and muscle strength in alcoholics. Alcohol Clin Exp Res. 1992; 16:986-990.
• Health & Medicine. (Statistical Data Included) American Fitness, July, 1999 Tannen RL. Effects of potassium on blood pressure control. Ann Intern Med. 1983; 98(part 2):773-780.
• Heaney RP. Calcium, dairy products and osteoporosis. J Am Coll Nutr. 2000; 19(2 Suppl):83S-99S.
• Hussain S, Ali SF. Manganese scavenges superoxide and hydroxyl radicals: an in vitro study in rats. Neuroscience Letters. 1999; 261:21-24.
• ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58,050 patients with suspected acute myocardial infarction. Lancet. 1995; 345:669-685.
• Jorde R, Sundsfjord J, Haug E, et al. Relation between low calcium intake, parathyroid hormone, and blood pressure. Hypertension 2000;35:1154-1159.
• Kao WHL, Folsom AR, Nieto J, et al. Serum and dietary magnesium and the risk for type 2 diabetes mellitus (editorial). Arch. Int Med. 1999; 159:2151-2159.
• Keen CL, Ensunsa JL, Watson MH, et al. Nutritional aspects of manganese from experimental studies. Neurotoxicol. 1999; 20:213-223.
• Krieger D, Krieger S, Jansen O, et al. Manganese and chronic hepatic encephalopathy. Lancet. 1995; 346:270-274.
• Lim R, Herzog WR. Magnesium for cardiac patients: is it a valuable treatment supplement? Contemp Int Med. 1998; 10:6-9.
• Lipkin M, Newmark H. Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med. 1985; 313:1381-1384.
• Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995; 333:201-205.
• Martini LA. Magnesium supplementation and bone turnover. Nutr Rev. 1999; 57:227-229.
• Mauskop A, Altura BM. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci. 1998; 5:24-27.
• Nielsen FH. Studies on the relationship between boron and magnesium which possibly affects the formation and maintenance of bones. Magnes Trace Elem. 1990;9:61-69
• Nielsen FH. Ultratrace minerals. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease, 9th ed. Baltimore, MD: Williams and Wilkins; 1999:283-303.
• Oginni LM, Sharp CA, Worsfold M, et al. Healing of rickets after calcium supplementation. Lancet. 1999; 353:296-297.
• Orchard TJ. Magnesium and type 2 diabetes mellitus (editorial). Arch Int Med. 1999; 159:2119-2120.
• Paolisso G, Sgamabato S, Pizza G, et al. Improved insulin response and action by chronic magnesium administration in aged NIDDM. Diabetes Care. 1989; 12:265-269.
• Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996; 16:257-263.
• Recker RR. Calcium absorption and achlorhydria. N Engl J Med. 1985; 313:70-73. Reid IR, Ames RW, Evans MC, et al. Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med. 1993; 328:460-464.
• Rivlin RS. Magnesium deficiency and alcohol intake: mechanisms, clinical significance and possible relation to cancer development (a review). J Am Coll Nutr. 1994; 13:416-423.
• Roberts JM. Magnesium for preeclampsia and eclampsia. N Engl J Med. 1995; 333:250-251.
• Roffe C, Fletcher S, Woods KL. Investigation of the effects of intravenous magnesium sulphate on cardiac rhythm in acute myocardial infarction. Br Heart J. 1994; 71:141-145.
• Saris N-EL, Mervaala E, Karppanen H, et al. Magnesium. An update on physiological, clinical and analytical aspects (review). Clinica Chimica Acta. 2000; 294:1-26.
• Shils ME. Magnesium. In: Shils M, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:169-192.
• Singh MA. Combined exercise and dietary intervention to optimize body composition in aging. Ann N Y Acad Sci. 1998 Nov 20;854:378-93.
• Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000; 283:2822-2825.
• Sojka JE. Magnesium supplementation and osteoporosis. Nutr Rev. 1995; 53:71-80.
• Strause L, Saltman P, Glowacki J. The effect of deficiencies of manganese and copper on osteo-induction and on resorption of bone particles in rats. Calcif Tissue Int. 1987; 41:145-150
• Strause L, Saltman P, Smith KT, et al. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr. 1994; 124:1060-1064.
• Talbot JR, Guardo P, Seccia S, et al. Calcium bioavailability and parathyroid hormone acute changes after oral intake of dairy and nondairy products in healthy volunteers. Osteoporosis Int. 1999; 10:137-142.
• Tobian L. Salt and hypertension. Lessons from animal models that relate to human hypertension. Hypertension. 1991; 17:152-158.
• Tosiello L. Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med. 1998; 156:1143-1148.
• Wargovich MJ, Eng VWS, Newmark HL. Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium. Cancer Lett. 1984; 23:253-258.
• Weaver CM, Heaney RP. Calcium. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:141-155.
• Wolf RL, Cauley JA, Baker CE, et al. Factors associated with calcium absorption efficiency in pre- and perimenopausal women. Am J Clin Nutr. 2000; 72:466-471.
• Woods KL, Fletcher S. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1994; 343:816-819.
• Zemel MB, Shi H, Greer B, et al. Regulation of adiposity by dietary calcium. FASEB J. 2000; 14:1132-1138.

愛尚它^®強鈣配方粉末有何獨特之處？ 

對於建構並維持強壯的骨骼來說，鈣是一種不可或缺的元素。愛尚它強鈣配方粉末透過等滲壓溶液，為人體提供適量的鈣、維生素D3、維生素B2、錳、鎂及維生素C，讓人體能迅速吸收。愛尚它營養補充食品與眼淚、血漿及乳汁等人體體液具有類似的特性。人體內的各種液體都有特定的濃度，稱之為滲透壓。人體的一般滲透壓是等滲壓的，讓身體的所有組織得以維持穩定的狀態。一種物質要經過代謝作用被人體利用前，必須轉為等滲狀態。 

另外，吸收的效率也受消化系統影響。所有物質要從胃部進入小腸被人體吸收前，必須經過一個分解過程。這消化過程可讓物質流失部份營養，而且整個過程也非常耗時！ 

現在，等滲壓過程的秘密將逐漸解開。當一種等滲壓物質進入人體時，會迅速被吸收進入血液。透過等滲壓溶液，物質的營養流失少，使營養吸收高度有效。這過程全沒人為因素，等滲壓溶液是天然的營養輸送系統。其天然的檸檬萊姆口味，也較一般口嚼型的鈣片美味可口。

常見問題： 

為甚麼要補充鈣質？
人人都需要鈣。除了有助於維持骨骼健康外，在作為礦物質上，鈣還擔當活躍的角色。愛尚它^®強鈣配方粉末還促進正常的肌肉收縮及骨骼健康。每日食用鈣補充品是防止及處理鈣質不足的關鍵。

我並非老年女士，為甚麼要食用鈣補充品？
不論任何年齡，在調節身體眾多過程中，鈣均扮演著相當重要的角色。雖然年紀大的女性較容易有鈣質流失，但年輕女性、懷孕及哺乳的婦女、正在發育的孩童、甚至是男性都應該食用鈣補充品。

年輕女性需要更多的鈣來鞏固骨骼。懷孕及哺乳的婦女需要額外的鈣供新細胞健康成長或餵哺母乳。

建議開始食用愛尚它^®強鈣配方粉末的年齡為多少？
我們建議18歲或以上的成年人均可食用愛尚它^®強鈣配方粉末。

為甚麼與水混合後杯裏會出現顆粒狀的沉澱物？
人人飲用的水都不同；有些水含有較高濃度的礦物質，而水的酸鹼度也因地理位置及自來水的品質而有所不同，因而導致溶液的飽和點不同。為確保我們的溶液不受酸鹼度或礦物質濃度影響而達到飽和點，我們將配方的份量提升至很高，因此每一份愛尚它強鈣配方粉末都包含正確份量的鈣。杯內的沉積物是因為溶液超過了飽和點而造成，這情況在醶性高或礦物質含量高的自來水中很常見。

我應該食用那一種形式的鈣？
碳酸鈣是鈣的最佳形式，因為碳酸鈣能提高吸收度，因此能更有效地被人體使用。此外，鈣連同鎂、錳、維生素C、維生素B2及鉀一起會更容易被人體吸收。愛尚它強鈣配方粉末含有碳酸鈣，添加其他所需多種維生素及礦物質，並調製為等滲壓形態，以使人體對鈣的使用及吸收提升至最高，並避免如很多鈣片或膠囊一樣導致營養流失的情況。

愛尚它^®強鈣配方粉末主要好處： 

·     鈣：構成牙齒與骨骼的主要成分。有助維持心臟、肌肉正常收縮及神經的感應性。有助控制細胞的通透性。維持骨骼及牙齒的健康。

·     維生素D：有助鈣及磷的吸收及利用。幫助骨骼及牙齒的生長發育。幫助維持血鈣的正常濃度。維持神經、肌肉生理的正常功能。幫助骨骼鈣化。

·     鎂：構成牙齒與骨骼的成分。與鈉、鉀、鈣共同維持心臟、肌肉及神經等正常功能。

愛尚它^®強鈣配方粉末的主要成份： 

鈣

奶類含有高濃度的鈣，其他含豐富鈣質的食物包括羽衣甘藍、大白菜、芥菜、綠花椰菜、青江菜及豆腐。鈣是一種必需礦物質，具有多方面的生物用途，存在於骨骼中的鈣主要為羥基磷灰石的形式(Ca₁₀ (PO₄)₆ (OH)₂)。 

羥基磷灰石約佔骨骼整體重量的四成。骨骼擁有結構上的先決條件，並作為鈣的儲存庫。除了作為骨頭及牙齒的主要成份外，鈣還支援正常的肌肉收縮、神經健康、心跳節奏、血液凝固等重要生理功能。

人體每日必需攝取足夠的鈣，以維持最佳的骨質密度、骨骼及牙齒健康，另外，鈣還顯示能舒緩女性經前症候群引起的不適。若人體每日吸收的鈣質不足，就會從骨頭裏提取鈣來使用。

鎂

富含鎂的食物包括粗穀類、堅果及綠色蔬菜。綠葉蔬菜由於其葉綠素含量高，因此是鎂的豐富來源。肉類、澱粉、奶製品及精製或加工食品的鎂含量較低。 

鎂是骨頭內礦物質部份的其中一種成份，能支援成年人體內鉀及鈣的正常代謝。鎂能有助鉀、磷、鈣維持正常含量。鎂亦支援細胞內鈣的傳送，以供人體使用。鎂促進肌肉及神經組織的正常功能，以及蛋白質、脂質及碳水化合物的正常合成。 

鎂促進正常的神經功能及新陳代謝。很重要的是，鎂還支援人體發展健康骨骼、牙齒及肌肉的能力。鎂與鈣及維生素D相互合作，有助維持骨骼強壯。 

錳

錳是一種大量存在於植物及動物物質內的礦物質。含錳最豐富的食物來源包括全穀物、堅果、葉菜類及茶。含錳濃度最高的是穀物的穀皮部份，但通常穀物在加工時，穀皮都會被去除。 

人體組織只含有微量的錳元素，主要儲存於骨頭、肝臟、腎臟及胰臟。

維生素B2

維生素B2存在於肝臟、奶類製品、深綠色蔬菜及部份海鮮中。維生素B2的角色是輔酵素，與其他維生素B合作。維生素B2促進人類正常生長，並增進皮膚健康。維生素B2作為電子輸送鏈的一部份，能促進食物轉化成能量的正常過程，在微觀的層面上推動細胞能量。維生素B2為水溶性，除非是極微量，否則不可被儲存於體內，因此，必須每日補充。 

維生素C

蘊藏最豐富維生素C的食物來源包括所有柑橘類水果（柳橙、葡萄柚、檸檬及柑橘）、草莓、蕃茄、綠花椰菜、小甘藍、椒類及哈蜜瓜。維生素C是一種「脆弱」的維生素，經過烹煮或食物曝露於氧氣中就很容易受損。 

維生素C支援身體使用其他多種維生素及礦物質的能力，如：硫胺素、核黃素、泛酸、生物素、葉酸、B12、視黃酫、α-生育酚及礦物鈣。維生素C在正常的葉酸及部份氨基酸的代謝作用上，擔當輔因子或輔助者的角色。作為一種有效的抗氧化物，維生素C還支援鐵在小腸的吸收，並支援膠原蛋白的正常合成。 

維生素C 成為了全球最受歡迎的維生素。由於人體自身不能製造維生素C ，因此，這亦成為了人們需要服用維生素C補充品最有說服力的理據。 

壓力問題也可能與維生素C 不足有關。另外，吸煙及部份藥物或會阻礙人體吸收維生素C的能力。由於維生素C為水溶性，因此每日都會排泄出體外，而因為人們日常進食的食物維生素C含量不足，所以服用補充品會對人體有益。 

維生素D

人類取得維生素D的主要途徑為適量曬太陽。含有維生素D的食物來源包括添加維生素D的奶類、魚肝油及含脂肪魚類如鮭魚，而蛋黃及肝臟也含少量維生素D。 

維生素D促進鈣及磷的吸收，並支援幾種參與鈣的吸收及儲存過程的蛋白質製造。維生素D與鈣相互合作，促進骨骼強壯、堅固。 

支持愛尚它^®強鈣配方粉末的科學研究：

• Abbott L, Nadler J, Rude RK. Magnesium deficiency in alcoholism: possible contribution to osteoporosis and cardiovascular disease in alcoholics. Alcohol Clin Exp Res. 1994; 18:1076-1082.
• Allender PS, Cutler JA, Follman D, et al. Dietary calcium and blood pressure: meta—analysis of randomized clinical trials. Ann Intern Med. 1996; 124:825-831.
• Altura BM, Altura BT. Role of magnesium and calcium in alcohol-induced hypertension and strokes as probed by in vivo television microscopy, digital image microscopy, optical spectroscopy, 31P-NMR, spectroscopy and a unique magnesium ion-selective electrode. Alcohol Clin Exp Res. 1994; 18:1057-1068.
• Baly DL, Schneiderman JS, Garcia-Welsh AL. Effect of manganese deficiency on insulin binding, glucose transport and metabolism in rat adipocytes. J Nutr. 1990; 120:1075-1079.
• Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med 1999;340:101-107.
• Baron JA, Tosteson TD, Wargovich MJ, et al. Calcium supplementation and rectal mucosal proliferation: a randomized controlled trial. J Natl Cancer Inst 1995;87:1303-1307.
• Baxter GF, Sumeray MS, Walker JM. Infant size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studies. Lancet. 1996; 348:1424-1426.
• Bell L, Halstenson CE, Halstenson CJ, et al. Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med. 1992; 152:2441-2444.
• Bostick RM, Kushi LH, Wu Y, et al. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 1999;149:151-160.
• Britton J, Pavord I, Richards K, et al. Dietary magnesium, lung function, wheezing, and airway hyper-reactivity in a random adult population sample. Lancet. 1994; 344:357-362.
• Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med. 1996; 125:961-968.
• Casscells W. Magnesium and myocardial infarction. Lancet. 1994; 343:807-809.
• Christiansen CW, Rieder MA, Silverstein EL, Gencheff NE. Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Circulation. 1995; 92:2617-2621.
• Christin Marandino, Vegetarian Times, August 1998
• Curhan GC, Willett WC, Speizer FE, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk of kidney stones in women. Ann Intern Med. 1997; 126:497-504.
• Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density on men and women 65 years of age and older. N Engl J Med. 1997; 337:670-676.
• de Lourdes Lima M, Cruz T, Carreiro Pousada J, et al. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care. 1998; 21:682-686.
• Dietary Reference Intakes for Calcium, Phosphorous, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press; 1997.
• Durlach J, Durlach V, Bac P, et al. Magnesium and therapeutics. Magnes Res. 1994; 7:313-328.
• Elisaf M, Merkouropoulos M, Tsianos EV. Siamopoulos KC. Pathogenetic mechanisms of hypomagnesemia in alcoholic patients. J Trace Elem Med Biol. 1995; 9:210-214.
• Facchinetti F, Borella P, Sances G, et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol. 1991; 78:177-181.
• Garland CF, Garland FC, Gorham ED. Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann NY Acad Sci. 1999; 889:107-119.
• Gong H, Amemiya T. Optic nerve changes in manganese-deficient rats. Exp Eye Res. 1999; 68:313-320.
• Gullestad L, Dolva LO, Soyland E, et al. Oral magnesium supplementation improves metabolic variables and muscle strength in alcoholics. Alcohol Clin Exp Res. 1992; 16:986-990.
• Health & Medicine. (Statistical Data Included) American Fitness, July, 1999 Tannen RL. Effects of potassium on blood pressure control. Ann Intern Med. 1983; 98(part 2):773-780.
• Heaney RP. Calcium, dairy products and osteoporosis. J Am Coll Nutr. 2000; 19(2 Suppl):83S-99S.
• Hussain S, Ali SF. Manganese scavenges superoxide and hydroxyl radicals: an in vitro study in rats. Neuroscience Letters. 1999; 261:21-24.
• ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58,050 patients with suspected acute myocardial infarction. Lancet. 1995; 345:669-685.
• Jorde R, Sundsfjord J, Haug E, et al. Relation between low calcium intake, parathyroid hormone, and blood pressure. Hypertension 2000;35:1154-1159.
• Kao WHL, Folsom AR, Nieto J, et al. Serum and dietary magnesium and the risk for type 2 diabetes mellitus (editorial). Arch. Int Med. 1999; 159:2151-2159.
• Keen CL, Ensunsa JL, Watson MH, et al. Nutritional aspects of manganese from experimental studies. Neurotoxicol. 1999; 20:213-223.
• Krieger D, Krieger S, Jansen O, et al. Manganese and chronic hepatic encephalopathy. Lancet. 1995; 346:270-274.
• Lim R, Herzog WR. Magnesium for cardiac patients: is it a valuable treatment supplement? Contemp Int Med. 1998; 10:6-9.
• Lipkin M, Newmark H. Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med. 1985; 313:1381-1384.
• Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995; 333:201-205.
• Martini LA. Magnesium supplementation and bone turnover. Nutr Rev. 1999; 57:227-229.
• Mauskop A, Altura BM. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci. 1998; 5:24-27.
• Nielsen FH. Studies on the relationship between boron and magnesium which possibly affects the formation and maintenance of bones. Magnes Trace Elem. 1990;9:61-69
• Nielsen FH. Ultratrace minerals. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease, 9th ed. Baltimore, MD: Williams and Wilkins; 1999:283-303.
• Oginni LM, Sharp CA, Worsfold M, et al. Healing of rickets after calcium supplementation. Lancet. 1999; 353:296-297.
• Orchard TJ. Magnesium and type 2 diabetes mellitus (editorial). Arch Int Med. 1999; 159:2119-2120.
• Paolisso G, Sgamabato S, Pizza G, et al. Improved insulin response and action by chronic magnesium administration in aged NIDDM. Diabetes Care. 1989; 12:265-269.
• Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996; 16:257-263.
• Recker RR. Calcium absorption and achlorhydria. N Engl J Med. 1985; 313:70-73. Reid IR, Ames RW, Evans MC, et al. Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med. 1993; 328:460-464.
• Rivlin RS. Magnesium deficiency and alcohol intake: mechanisms, clinical significance and possible relation to cancer development (a review). J Am Coll Nutr. 1994; 13:416-423.
• Roberts JM. Magnesium for preeclampsia and eclampsia. N Engl J Med. 1995; 333:250-251.
• Roffe C, Fletcher S, Woods KL. Investigation of the effects of intravenous magnesium sulphate on cardiac rhythm in acute myocardial infarction. Br Heart J. 1994; 71:141-145.
• Saris N-EL, Mervaala E, Karppanen H, et al. Magnesium. An update on physiological, clinical and analytical aspects (review). Clinica Chimica Acta. 2000; 294:1-26.
• Shils ME. Magnesium. In: Shils M, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:169-192.
• Singh MA. Combined exercise and dietary intervention to optimize body composition in aging. Ann N Y Acad Sci. 1998 Nov 20;854:378-93.
• Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000; 283:2822-2825.
• Sojka JE. Magnesium supplementation and osteoporosis. Nutr Rev. 1995; 53:71-80.
• Strause L, Saltman P, Glowacki J. The effect of deficiencies of manganese and copper on osteo-induction and on resorption of bone particles in rats. Calcif Tissue Int. 1987; 41:145-150
• Strause L, Saltman P, Smith KT, et al. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr. 1994; 124:1060-1064.
• Talbot JR, Guardo P, Seccia S, et al. Calcium bioavailability and parathyroid hormone acute changes after oral intake of dairy and nondairy products in healthy volunteers. Osteoporosis Int. 1999; 10:137-142.
• Tobian L. Salt and hypertension. Lessons from animal models that relate to human hypertension. Hypertension. 1991; 17:152-158.
• Tosiello L. Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med. 1998; 156:1143-1148.
• Wargovich MJ, Eng VWS, Newmark HL. Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium. Cancer Lett. 1984; 23:253-258.
• Weaver CM, Heaney RP. Calcium. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:141-155.
• Wolf RL, Cauley JA, Baker CE, et al. Factors associated with calcium absorption efficiency in pre- and perimenopausal women. Am J Clin Nutr. 2000; 72:466-471.
• Woods KL, Fletcher S. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1994; 343:816-819.
• Zemel MB, Shi H, Greer B, et al. Regulation of adiposity by dietary calcium. FASEB J. 2000; 14:1132-1138.

愛尚它^®強鈣配方粉末有何獨特之處？ 

對於建構並維持強壯的骨骼來說，鈣是一種不可或缺的元素。愛尚它強鈣配方粉末透過等滲壓溶液，為人體提供適量的鈣、維生素D3、維生素B2、錳、鎂及維生素C，讓人體能迅速吸收。愛尚它營養補充食品與眼淚、血漿及乳汁等人體體液具有類似的特性。人體內的各種液體都有特定的濃度，稱之為滲透壓。人體的一般滲透壓是等滲壓的，讓身體的所有組織得以維持穩定的狀態。一種物質要經過代謝作用被人體利用前，必須轉為等滲狀態。 

另外，吸收的效率也受消化系統影響。所有物質要從胃部進入小腸被人體吸收前，必須經過一個分解過程。這消化過程可讓物質流失部份營養，而且整個過程也非常耗時！ 

現在，等滲壓過程的秘密將逐漸解開。當一種等滲壓物質進入人體時，會迅速被吸收進入血液。透過等滲壓溶液，物質的營養流失少，使營養吸收高度有效。這過程全沒人為因素，等滲壓溶液是天然的營養輸送系統。其天然的檸檬萊姆口味，也較一般口嚼型的鈣片美味可口。

常見問題： 

為甚麼要補充鈣質？
人人都需要鈣。除了有助於維持骨骼健康外，在作為礦物質上，鈣還擔當活躍的角色。愛尚它^®強鈣配方粉末還促進正常的肌肉收縮及骨骼健康。每日食用鈣補充品是防止及處理鈣質不足的關鍵。

我並非老年女士，為甚麼要食用鈣補充品？
不論任何年齡，在調節身體眾多過程中，鈣均扮演著相當重要的角色。雖然年紀大的女性較容易有鈣質流失，但年輕女性、懷孕及哺乳的婦女、正在發育的孩童、甚至是男性都應該食用鈣補充品。

年輕女性需要更多的鈣來鞏固骨骼。懷孕及哺乳的婦女需要額外的鈣供新細胞健康成長或餵哺母乳。

建議開始食用愛尚它^®強鈣配方粉末的年齡為多少？
我們建議18歲或以上的成年人均可食用愛尚它^®強鈣配方粉末。

為甚麼與水混合後杯裏會出現顆粒狀的沉澱物？
人人飲用的水都不同；有些水含有較高濃度的礦物質，而水的酸鹼度也因地理位置及自來水的品質而有所不同，因而導致溶液的飽和點不同。為確保我們的溶液不受酸鹼度或礦物質濃度影響而達到飽和點，我們將配方的份量提升至很高，因此每一份愛尚它強鈣配方粉末都包含正確份量的鈣。杯內的沉積物是因為溶液超過了飽和點而造成，這情況在醶性高或礦物質含量高的自來水中很常見。

我應該食用那一種形式的鈣？
碳酸鈣是鈣的最佳形式，因為碳酸鈣能提高吸收度，因此能更有效地被人體使用。此外，鈣連同鎂、錳、維生素C、維生素B2及鉀一起會更容易被人體吸收。愛尚它強鈣配方粉末含有碳酸鈣，添加其他所需多種維生素及礦物質，並調製為等滲壓形態，以使人體對鈣的使用及吸收提升至最高，並避免如很多鈣片或膠囊一樣導致營養流失的情況。